Evolva Holding SA (EVE.SW)

CHF 1.18

(1.72%)

Total Assets Summary of Evolva Holding SA

Evolva Holding SA's latest annual total assets in 2023 was 9.82 Million CHF , down -92.5% from previous year.
Evolva Holding SA's latest quarterly total assets in 2024 Q2 was 7.97 Million CHF , down 0.0% from previous quarter.
Evolva Holding SA reported annual total assets of 131 Million CHF in 2022, down -16.11% from previous year.
Evolva Holding SA reported annual total assets of 156.17 Million CHF in 2021, down -6.42% from previous year.
Evolva Holding SA reported quarterly total assets of 9.82 Million CHF for 2023 FY, down -92.5% from previous quarter.
Evolva Holding SA reported quarterly total assets of 9.82 Million CHF for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Evolva Holding SA (2023 - 2005)

Historical Annual Total Assets of Evolva Holding SA (2023 - 2005)

Year	Total Assets	Total Assets Growth
2023	9.82 Million CHF	-92.5%
2022	131 Million CHF	-16.11%
2021	156.17 Million CHF	-6.42%
2020	166.89 Million CHF	-13.11%
2019	192.07 Million CHF	-9.83%
2018	213.01 Million CHF	-11.18%
2017	239.82 Million CHF	20.98%
2016	198.23 Million CHF	-14.64%
2015	232.23 Million CHF	9.23%
2014	212.61 Million CHF	101.96%
2013	105.27 Million CHF	16.49%
2012	90.37 Million CHF	-15.14%
2011	106.49 Million CHF	41.95%
2010	75.02 Million CHF	-19.24%
2009	92.89 Million CHF	109.44%
2008	44.35 Million CHF	-48.74%
2007	86.52 Million CHF	3.31%
2006	83.75 Million CHF	-38.26%
2005	135.65 Million CHF	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	7.97 Million CHF	0.0%
2023 FY	9.82 Million CHF	-92.5%
2023 Q4	9.82 Million CHF	0.0%
2023 Q2	53.13 Million CHF	0.0%
2022 Q4	131 Million CHF	0.0%
2022 Q2	140.18 Million CHF	0.0%
2022 FY	131 Million CHF	-16.11%
2021 Q4	156.17 Million CHF	0.0%
2021 Q2	156.12 Million CHF	0.0%
2021 FY	156.17 Million CHF	-6.42%
2020 FY	166.89 Million CHF	-13.11%
2020 Q2	177.33 Million CHF	0.0%
2020 Q4	166.89 Million CHF	0.0%
2019 Q2	200.98 Million CHF	0.0%
2019 FY	192.07 Million CHF	-9.83%
2019 Q4	192.07 Million CHF	0.0%
2018 Q2	234.56 Million CHF	0.0%
2018 Q4	213.01 Million CHF	0.0%
2018 FY	213.01 Million CHF	-11.18%
2017 FY	239.82 Million CHF	20.98%
2017 Q4	239.82 Million CHF	0.0%
2017 Q2	174.29 Million CHF	0.0%
2016 Q4	198.23 Million CHF	0.0%
2016 Q2	212.66 Million CHF	0.0%
2016 FY	198.23 Million CHF	-14.64%
2015 Q4	232.23 Million CHF	0.0%
2015 FY	232.23 Million CHF	9.23%
2015 Q2	190.99 Million CHF	0.0%
2014 FY	212.61 Million CHF	101.96%
2014 Q2	136.77 Million CHF	0.0%
2014 Q4	212.61 Million CHF	0.0%
2013 Q4	105.27 Million CHF	0.0%
2013 Q2	114.67 Million CHF	0.0%
2013 FY	105.27 Million CHF	16.49%
2012 Q2	97.88 Million CHF	0.0%
2012 Q4	90.37 Million CHF	0.0%
2012 FY	90.37 Million CHF	-15.14%
2011 Q4	106.49 Million CHF	0.0%
2011 FY	106.49 Million CHF	41.95%
2011 Q2	64.44 Million CHF	0.0%
2010 Q2	85.36 Million CHF	0.0%
2010 FY	75.02 Million CHF	-19.24%
2010 Q4	75.02 Million CHF	0.0%
2009 Q4	92.89 Million CHF	0.0%
2009 FY	92.89 Million CHF	109.44%
2008 FY	44.35 Million CHF	-48.74%
2007 FY	86.52 Million CHF	3.31%
2006 FY	83.75 Million CHF	-38.26%
2005 FY	135.65 Million CHF	0.0%

Peer Total Assets Comparison of Evolva Holding SA

Name	Total Assets	Total Assets Difference
Addex Therapeutics Ltd	4.64 Million CHF	-111.767%
BB Biotech AG	2.63 Billion CHF	99.627%
Basilea Pharmaceutica AG	173.28 Million CHF	94.328%
Idorsia Ltd	499.99 Million CHF	98.034%
Kuros Biosciences AG	75.9 Million CHF	87.052%
Molecular Partners AG	198.35 Million CHF	95.045%
Relief Therapeutics Holding AG	76.39 Million CHF	87.134%
Santhera Pharmaceuticals Holding AG	109.62 Million CHF	91.035%